Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: A novel model for studying the pathomechanisms of inflammatory bowel disease cytokines

References

• Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998; 141: 1539–50
   PubMed Web of Science ®Google Scholar
• Anderson JM, Van Itallie CM. Tight Junctions. Curr Biol 2008; 18: 941–3
   Web of Science ®Google Scholar
• Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 2003; 18: 479–97
   PubMed Web of Science ®Google Scholar
• Bürgel N, Bojarski C, Mankertz J, Zeitz M, Fromm M, Schulzke JD. Mechanisms of diarrhea in collagenous colitis. Gastroenterology 2002; 123: 433–43
   PubMed Web of Science ®Google Scholar
• Schmitz H, Fromm M, Bentzel CJ, Scholz P, Detjen K, Mankertz J, et al. Tumor necrosis factor-alpha (TNF-alpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 1999; 112: 137–6
   PubMed Web of Science ®Google Scholar
• Schürmann G, Brüwer M, Klotz A, Schmid KW, Senninger N, Zimmer KP. Transepithelial transport processes at the intestinal mucosa in inflammatory bowel disease. Int J Colorectal Dis 1999; 14: 41–6
   PubMed Web of Science ®Google Scholar
• Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 2005; 166: 409–9
   PubMed Web of Science ®Google Scholar
• Garside P, Bunce C, Tomlinson RC, Nichols BL, Mowat AM. Analysis of enteropathy induced by tumour necrosis factor alpha. Cytokine 1993; 5: 24–30
   PubMed Web of Science ®Google Scholar
• Guy-Grand D, DiSanto JP, Henchoz P, Malassis-Séris M, Vassalli P. Small bowel enteropathy: role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-gamma, TNF) in the induction of epithelial cell death and renewal. Eur J Immunol 1998; 8: 730–4
   Google Scholar
• Gitter AH, Bendfeldt K, Schulzke JD, Fromm M. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. Faseb J 2000; 4: 1749–3
   Web of Science ®Google Scholar
• Mankertz J, Tavalali S, Schmitz H, Mankertz A, Riecken EO, Fromm M, et al. Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J Cell Sci 2000; 13: 2085–90
   Google Scholar
• Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003; 71: 6164–2
   Web of Science ®Google Scholar
• Prasad S, Mingrino R, Kaukinen K, Hayes KL, Powell RM, MacDonald TT, et al. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest 2005; 85: 1139–62
   PubMed Web of Science ®Google Scholar
• Utech M, Ivanov AI, Samarin SN, Bruewer M, Turner JR, Mrsny RJ, et al. Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 2005; 16: 5040–52
   PubMed Web of Science ®Google Scholar
• Ma TY, Boivin MA, Ye D, Pedram A, Said HM. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 2005; 288: G422–30
   PubMed Web of Science ®Google Scholar
• Ye D, Ma I, Ma TY. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 2006; 290: G496–504
   PubMed Web of Science ®Google Scholar
• Wang F, Schwarz BT, Graham WV, Wang Y, Su L, Clayburgh DR, et al. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 2006; 131: 1153–63
   PubMed Web of Science ®Google Scholar
• Gitter AH, Wullstein F, Fromm M, Schulzke JD. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 2001; 121: 1320–8
   PubMed Web of Science ®Google Scholar
• Suenaert P, Bulteel V, Lemmens L, Noman M, Geypens B, Van Assche G, et al. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am J Gastroenterol 2002; 97: 2000–4
   PubMed Web of Science ®Google Scholar
• Zeissig S, Bojarski C, Buergel N, Mankertz J, Zeitz M, Fromm M. Down-regulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut 2004; 53: 1295–302
   PubMed Web of Science ®Google Scholar
• Barrett KE. Immune-related intestinal chloride secretion. III. Acute and chronic effects of mast cell mediators on chloride secretion by a human colonic epithelial cell line. J Immunol 1991; 147: 959–64
   PubMed Web of Science ®Google Scholar
• Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005; 129: 550–64
   PubMed Web of Science ®Google Scholar
• Cooke HJ. Neuroimmune signaling in regulation of intestinal ion transport. Am J Physiol 1994; 266: G167–78
   PubMed Web of Science ®Google Scholar
• Powell DW, Adegboyega PA, Di Mari JF, Mifflin RC. Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer. Am J Physiol Gastrointest Liver Physiol 2005; 289: G2–7
   PubMed Web of Science ®Google Scholar
• Grotjohann I, Schulzke JD, Fromm M. Electrogenic Na+ transport in rat late distal colon by natural and synthetic glucocorticosteroids. Am J Physiol 1999; 276: G491–8
   PubMedGoogle Scholar
• Fromm M, Schulzke JD, Hegel U. Control of electrogenic Na+ absorption in rat late distal colon by nanomolar aldosterone added in vitro. Am J Physiol 1993; 264: E68–73
   PubMed Web of Science ®Google Scholar
• Schulzke JD, Fromm M, Bentzel CJ, Zeitz M, Menge H, Riecken EO. Ion transport in the experimental short bowel syndrome of the rat. Gastroenterology 1992; 102: 497–504
   PubMed Web of Science ®Google Scholar
• Tai YH, Tai CY. The conventional short-circuiting technique under-short-circuits most epithelia. J Membr Biol 1981; 59: 173–7
   PubMed Web of Science ®Google Scholar
• Schulzke JD, Fromm M, Menge H, Riecken EO. Impaired intestinal sodium and chloride transport in the blind loop syndrome of the rat. Gastroenterology 1987; 92: 693–8
   PubMed Web of Science ®Google Scholar
• Santos J, Yang PC, Söderholm JD, Benjamin M, Perdue MH. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 2001; 48: 630–6
   PubMed Web of Science ®Google Scholar
• Dawson DC. Na and Cl transport across the isolated turtle colon: parallel pathways for transmural ion movement. J Membr Biol 1977; 37: 213–33
   PubMed Web of Science ®Google Scholar
• Rahner C, Mitic LL, Anderson JM. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 2001; 120: 411–22
   PubMed Web of Science ®Google Scholar
• Barmeyer C, Harren M, Schmitz H, Heinzel-Pleines U, Mankertz J, Seidler U, et al. Mechanisms of diarrhea in the interleukin-2-deficient mouse model of colonic inflammation. Am J Physiol Gastrointest Liver Physiol 2004; 286: G244–52
   PubMed Web of Science ®Google Scholar
• Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 1999; 116: 301–9
   PubMed Web of Science ®Google Scholar
• Sanders DS. Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease. J Clin Pathol 2005; 58: 568–72
   PubMed Web of Science ®Google Scholar
• Madara JL, Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989; 83: 724–7
   PubMed Web of Science ®Google Scholar
• Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 2004; 286: G367–76
   PubMed Web of Science ®Google Scholar
• Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 2000; 279: G851–7
   PubMed Web of Science ®Google Scholar
• Amasheh S, Schmidt T, Mahn M, Florian P, Mankertz J, Tavalali S, et al. Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells. Cell Tissue Res 2005; 321: 89–96
   PubMed Web of Science ®Google Scholar
• Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002; 156: 1099–111
   PubMed Web of Science ®Google Scholar
• Amasheh S, Meiri N, Gitter AH, Schöneberg T, Mankertz J, Schulzke JD, et al. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 2002; 115: 4969–76
   PubMed Web of Science ®Google Scholar
• Alexandre MD, Lu Q, Chen YH. Overexpression of claudin-7 decreases the paracellular Cl- conductance and increases the paracellular Na+ conductance in LLC-PK1 cells. J Cell Sci 2005; 118: 2683–93
   PubMed Web of Science ®Google Scholar
• Poritz LS, Garver KI, Tilberg AF, Koltun WA. Tumor necrosis factor alpha disrupts tight junction assembly. J Surg Res 2004; 116: 14–8
   PubMed Web of Science ®Google Scholar
• Bruewer M, Utech M, Ivanov AI, Hopkins AM, Parkos CA, Nusrat A. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. Faseb J 2005; 19: 923–33
   PubMed Web of Science ®Google Scholar
• Ivanov AI, Nusrat A, Parkos CA. Endocytosis of the apical junctional complex: mechanisms and possible roles in regulation of epithelial barriers. Bioessays 2005; 27: 356–65
   PubMed Web of Science ®Google Scholar
• Ivanov AI, Nusrat A, Parkos CA. The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption. Novartis Found Symp 2004; 263: 115–24
   PubMedGoogle Scholar
• Gassler N, Rohr C, Schneider A, Kartenbeck J, Bach A, Obermüller N, et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 2001; 281: G216–28
   PubMed Web of Science ®Google Scholar
• Hollander D. Crohn's disease: a permeability disorder of the tight junction?. Gut 1988; 29: 1621–4
   PubMed Web of Science ®Google Scholar
• Bojarski C, Gitter AH, Bendfeldt K, Mankertz J, Schmitz H, Wagner S, et al. Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis. J Physiol 2001; 535: 541–52
   PubMed Web of Science ®Google Scholar
• Kersting S, Bruewer M, Schuermann G, Klotz A, Utech M, Hansmerten M, et al. Antigen transport and cytoskeletal characteristics of a distinct enterocyte population in inflammatory bowel diseases. Am J Physiol 2004; 165: 425–37
   Google Scholar
• Salik E, Tyorkin M, Mohan S, George I, Becker K, Oei E, et al. Antigen trafficking and accessory cell function in respiratory epithelial cells. Am J Respir Cell Mol Biol 1999; 21: 365–79
   PubMed Web of Science ®Google Scholar
• Martinez I, Sveinbjørnsson B, Vidal-Vanaclocha F, Asumendi A, Smedsrød B. Differential cytokine-mediated modulation of endocytosis in rat liver endothelial cells. Biochem Biophys Res Commun 1995; 212: 235–41
   PubMed Web of Science ®Google Scholar
• Söderholm JD, Streutker C, Yang PC, Paterson C, Singh PK, McKay DM, et al. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor α. Gut 2004; 53: 1817–24
   PubMed Web of Science ®Google Scholar
• Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992; 339: 89–91
   PubMed Web of Science ®Google Scholar
• Van Deventer SJ. Tumour necrosis factor and Crohn's disease. Gut 1997; 40: 443–8
   PubMed Web of Science ®Google Scholar
• Van Dullemen HM, de Jong E, Slors F, Tytgat GN, van Deventer SJ. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995; 109: 129–35
   PubMed Web of Science ®Google Scholar
• Zeissig S, Bürgel N, Günzel D, Richter J, Mankertz J, Wahnschaffe U, et al. Changes in expression and distribution of claudin-2, -5 and -8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007; 56: 61–72
   PubMed Web of Science ®Google Scholar
• Pender SL, Tickle SP, Docherty AJ, Howie D, Wathen NC, MacDonald TT. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 1997; 158: 1582–90
   PubMed Web of Science ®Google Scholar